| Autor: |
Bharathi Dr, Persis Johnson, Jisna Thomas, Abubaker Siddiq, Eldho Mathew Paul |
| Rok vydání: |
2016 |
| Předmět: |
|
| Zdroj: |
International Journal of Pharma Research and Health Sciences. 4:1210-1213 |
| ISSN: |
2348-6465 |
| DOI: |
10.21276/ijprhs.2016.03.10 |
| Popis: |
Received: 10 Jun 2016 Accepted: 27 Jun 2016 Background: Bronchial asthma is a chronic illness which creates a substantial burden on individuals and families. It is important to understand early risk factors to decrease asthma incidence. It usually requires a patient specific therapy to obtain maximum benefit to the patient. Objectives: The objectives were to evaluate prevalence of bronchial asthma, analyse the risk factors for bronchial asthma and the prescription pattern for treatment of bronchial asthma. Materials and Methods: This was a prospective observational study conducted at General Medicine department of Basaveshwara Medical College Hospital & research centre, Chitradurga for a period of six months. The study was approved by Institutional Ethical Committee of SJM College of Pharmacy Chitradurga. The data collected from medical records of in-patients and interviews with patient and/or care givers. The data was analyzed descriptively. Result: The study identified that males are more prone to develop asthma. The prevalence rate of asthma found to be 4.59%. Dust found to be more predominant among risk factors in asthmatic patients. In monotherapy, most commonly prescribed drug was budesonide, followed by salbutamol. theophylline with etiophylline was given to majority of patients as 2 drug regimen and 54 patients were prescribed with salbutamol with ipratropium bromide and theophylline with etiophylline which is a 4 drug regimen. Conclusion: Bronchial asthma is a chronic state which obliges a continues medical care. The proper awareness of the patients regarding triggering as well as risk factors can reduce the incidence of asthma. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
